Glenmark Pharma gets USFDA nod to market drug for relapsing multiple sclerosis
Admin
Oct 10, 2020 01:19
72
Drug major Glenmark Pharma on Wednesday said it has received final approval from the US health regulator for Dimethyl Fumarate delayed-release capsules, used for treatment of relapsing forms of multiple sclerosis in adults.
